Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

BD debuts compact flow cytometry cell analyzer

The new system supports a range of flow cytometry experiments.

By Brian Buntz | August 11, 2021

BD FAC Symphony A1Flow cytometry is a powerful technology given its ability to analyze the physical and chemical properties of cells and particles.

But many laboratories struggle to find space for advanced flow cytometry cell analyzers.

BD (NYSE:BDX) has responded to that challenge with its benchtop FACSymphony A1 cell analyzer.

BD designed the fluorescence-activated cell analyzer to support modern research demands in a small footprint.

The analyzer can precisely isolate single cells from complex samples. It supports small particle research as well as 16-color immunophenotyping.

The FACSymphony A1 “offers high-end technology and a cost-effective benchtop design,” surmised Thomas E. Polen, BD CEO, in a recent earnings calls.

The FACSymphony A1 cell analyzer supports various types of flow cytometry experiments. In addition, an optional small particle detector enables the analysis of extracellular vesicles.

BD recently debuted its spectral analyzer as well, which is known as the FACSymphony A5 SE.


Filed Under: Drug Discovery and Development, R&D World, RD
Tagged With: BD, Becton, Dickinson and Company, FACSymphony A1 cell analyzer, FACSymphony A5 SE, flow cytometry, flow cytometry cell analyzer
 

About The Author

Brian Buntz

As the pharma and biotech editor at WTWH Media, Brian has almost two decades of experience in B2B media, with a focus on healthcare and technology. While he has long maintained a keen interest in AI, more recently Brian has made making data analysis a central focus, and is exploring tools ranging from NLP and clustering to predictive analytics.

Throughout his 18-year tenure, Brian has covered an array of life science topics, including clinical trials, medical devices, and drug discovery and development. Prior to WTWH, he held the title of content director at Informa, where he focused on topics such as connected devices, cybersecurity, AI and Industry 4.0. A dedicated decade at UBM saw Brian providing in-depth coverage of the medical device sector. Engage with Brian on LinkedIn or drop him an email at bbuntz@wtwhmedia.com.

Related Articles Read More >

R&D
Inflation may slow, but R&D still hot, in this week’s R&D Power Index
Alzheimer's disease
How to build a foundation for the next phase of Alzheimer’s disease research
HIV CDC
Abbott researchers help discover a clue to an HIV cure
Thermo Fisher
Thermo Fisher Scientific acquires Propel Labs and its cell sorting tech
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE